Ethylisopropyllysergamide Explained

Ethylisopropyllysergamide (EIPLA) is an analog of lysergic acid diethylamide (LSD). In studies in mice, it was found to have approximately half the potency of LSD.[1] [2] [3]

See also

Notes and References

  1. Huang X, Marona-Lewicka D, Pfaff RC, Nichols DE . Drug discrimination and receptor binding studies of N-isopropyl lysergamide derivatives . Pharmacology, Biochemistry, and Behavior . 47 . 3 . 667–673 . March 1994 . 10.1016/0091-3057(94)90172-4 . 8208787 .
  2. Nichols DE . Dark Classics in Chemical Neuroscience: Lysergic Acid Diethylamide (LSD) . ACS Chemical Neuroscience . 9 . 10 . 2331–2343 . October 2018 . 10.1021/acschemneuro.8b00043 . 29461039 .
  3. Brandt SD, Kavanagh PV, Westphal F, Pulver B, Schwelm HM, Stratford A, Auwärter V, Halberstadt AL . Analytical and behavioral characterization of N-ethyl-N-isopropyllysergamide (EIPLA), an isomer of N6 -ethylnorlysergic acid N,N-diethylamide (ETH-LAD) . Drug Testing and Analysis . 16 . 2 . 187–198 . February 2024 . 37321559 . 10.1002/dta.3530 .

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Ethylisopropyllysergamide".

Except where otherwise indicated, Everything.Explained.Today is © Copyright 2009-2025, A B Cryer, All Rights Reserved. Cookie policy.